Tag: Biotechnology

Biocon subsidiary gets USFDA nod for generic drug for chronic heart failure

Posted on September 1, 2024 by filesadmin

1 min read Last Updated : Sep 01 2024 | 10:35 PM IST Biotechnology firm Biocon said its subsidiary

Lupin appoints Jeffrey Kindler, Alfonso ‘Chito’ Zulueta as independent dirs

Posted on May 9, 2024 by filesadmin

Traditional Indian jewellery is getting a makeover. (File photo) 2 min read Last Updated : May 09 2024 | 1:34

US-based Hedge fund Shah Capital urges Novavax board shake-up: Report

Posted on April 15, 2024 by filesadmin

1 min read Last Updated : Apr 15 2024 | 10:50 AM IST US-based hedge fund Shah Capital wrote

Decoding consumer resistance to biotechnology food crops

Posted on March 20, 2024 by filesadmin

All of us consume food, but not many are likely to be aware of food production systems. Yet consumers hold

Biocon subsidiary partners with Sandoz Australia

Posted on February 9, 2024 by filesadmin

Biocon’s subsidiary, Biocon Biologics Ltd (BBL), a fully integrated biosimilar company, has announced a five-year partnership with Sandoz AG (Sandoz).

IIL invests Rs 700 cr in new vaccine plant to combat livestock disease

Posted on December 28, 2023 by filesadmin

Biotechnology company Indian Immunologicals (IIL), under the National Dairy Development Board (NDDB), on Thursday announced the start of the

Glenmark Pharma, Teva settle drug pricing cases with US Dept of Justice

Posted on August 23, 2023 by filesadmin

Mumbai-based drugmaker Glenmark Pharmaceuticals said that it has entered into a pact with the US Department of Justice, Antitrust

Pfizer’s proposed $43 bn takeover of Seagen faces EU investigation

Posted on July 15, 2023 by filesadmin

Written by Samuel Stolton Pfizer’s proposed $43 billion acquisition of Seagen Inc will face a merger enforcement investigation in the

UK-based BenevolentAI to cut about 180 jobs as part of restructuring plan

Posted on May 28, 2023 by filesadmin

UK-based AI drug exploration company BenevolentAI has announced layoffs of around 180 employees as part of a restructuring plan that

Insulin maker GeneSys to invest $50-60 mn to set up plant in Hyderabad

Posted on May 21, 2023 by filesadmin

Biotech company GeneSys Biologics Pvt Ltd plans to invest US$50-60 million to construct a new large-scale bulk manufacturing facility in

Recent Posts